Status:
RECRUITING
Feasibility of Cough Monitoring in Children
Lead Sponsor:
University of Colorado, Denver
Conditions:
Cystic Fibrosis in Children
Eligibility:
All Genders
1-18 years
Brief Summary
Cystic fibrosis (CF) is a disease characterized by chronic airway infection and impaired mucociliary clearance, which predisposes those affected to recurrent pulmonary exacerbations (PEx) and progress...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Children with Cystic Fibrosis
- Diagnosis of CF based on 2 known CFTR mutations and/or sweat chloride \> 60 mmol/L
- Ages 1-18 years of age
- Clinically stable at the time of consent
- Exclusion Criteria
- Use of nocturnal positive pressure or supplemental oxygen
- Shared bedroom with sibling
- Use of oral or IV antibiotics within the past 2 weeks except for chronic azithromycin use
- Shared custody (i.e., the participant is splitting time between time households)
- Inclusion Criteria for Healthy Controls
- Ages 1-18
- Exclusion Criteria:
- Shared bedroom with sibling
- Underlying chronic respiratory or cardiac conditions including chronic cough, CF, asthma, obstructive sleep apnea, or congenital heart disease or other condition felt by the investigator to cause chronic nighttime symptoms
- Shared custody (i.e., the participant is splitting time between time households)
Exclusion
Key Trial Info
Start Date :
February 27 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06587126
Start Date
February 27 2024
End Date
December 1 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Colorado
Aurora, Colorado, United States, 80045